UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Increased by Oakworth Capital Inc.

Oakworth Capital Inc. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,986 shares of the healthcare conglomerate’s stock after acquiring an additional 349 shares during the quarter. Oakworth Capital Inc.’s holdings in UnitedHealth Group were worth $2,030,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Bellecapital International Ltd. raised its stake in UnitedHealth Group by 3.7% during the second quarter. Bellecapital International Ltd. now owns 14,891 shares of the healthcare conglomerate’s stock worth $7,583,000 after acquiring an additional 536 shares during the period. Meridian Financial Partners LLC raised its position in shares of UnitedHealth Group by 4.7% during the 2nd quarter. Meridian Financial Partners LLC now owns 2,848 shares of the healthcare conglomerate’s stock worth $1,607,000 after purchasing an additional 127 shares during the period. Mason & Associates Inc grew its stake in UnitedHealth Group by 23.0% during the 2nd quarter. Mason & Associates Inc now owns 4,106 shares of the healthcare conglomerate’s stock worth $2,091,000 after buying an additional 768 shares during the last quarter. TCW Group Inc. lifted its stake in UnitedHealth Group by 4.6% in the second quarter. TCW Group Inc. now owns 260,232 shares of the healthcare conglomerate’s stock valued at $132,526,000 after buying an additional 11,529 shares during the last quarter. Finally, Unique Wealth LLC grew its position in UnitedHealth Group by 12.7% in the 2nd quarter. Unique Wealth LLC now owns 3,233 shares of the healthcare conglomerate’s stock worth $1,641,000 after purchasing an additional 364 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 0.3 %

Shares of UNH traded down $1.93 during trading hours on Friday, reaching $577.68. The company’s stock had a trading volume of 2,728,939 shares, compared to its average volume of 4,224,914. The company has a 50 day moving average of $529.38 and a two-hundred day moving average of $507.45. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $591.54. The firm has a market cap of $533.44 billion, a price-to-earnings ratio of 35.31, a P/E/G ratio of 1.61 and a beta of 0.59. The company has a quick ratio of 0.85, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the prior year, the business posted $6.14 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Ratings Changes

A number of research analysts have issued reports on UNH shares. Argus boosted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Barclays raised their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday, August 13th. JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Finally, Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.